Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kiora Pharmaceuticals (KPRX) Interest Expenses (2016 - 2023)

Kiora Pharmaceuticals (KPRX) has disclosed Interest Expenses for 8 consecutive years, with $5984.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Interest Expenses changed N/A year-over-year to $5984.0, compared with a TTM value of $5984.0 through Sep 2024, changed N/A, and an annual FY2024 reading of $21446.0, up 92.65% over the prior year.
  • Interest Expenses was $5984.0 for Q4 2023 at Kiora Pharmaceuticals, up from $4132.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $5984.0 in Q4 2023 and bottomed at $108.0 in Q1 2019.
  • Average Interest Expenses over 4 years is $2168.2, with a median of $1359.5 recorded in 2021.
  • The sharpest move saw Interest Expenses crashed 64.47% in 2019, then decreased 1.29% in 2021.
  • Year by year, Interest Expenses stood at $109.0 in 2019, then surged by 3740.37% to $4186.0 in 2020, then fell by 1.29% to $4132.0 in 2021, then skyrocketed by 44.82% to $5984.0 in 2023.
  • Business Quant data shows Interest Expenses for KPRX at $5984.0 in Q4 2023, $4132.0 in Q4 2021, and $2033.0 in Q2 2021.